Feedback
ZYDUSLIFE 
Reputation: 642,681 • Jul 10, 2023 3:13 PM
Zydus Lifesciences gains on USFDA's all-clear for Ahmedabad unit
The company has also received final approval from the United States Food and Drug Administration for Oxcarbazepine tablets. Oxcarbazepine is used to treat epilepsy
Moneycontrol
Vote
Comment
Share
NSE:ZYDUSLIFE price when posted: 585.05